Cargando…

Editorial: Classical and Novel Biomarkers for Cardiovascular Disease

Detalles Bibliográficos
Autores principales:	Perticone, Maria, Molfino, A., Maio, R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241513/ https://www.ncbi.nlm.nih.gov/pubmed/35783859 http://dx.doi.org/10.3389/fcvm.2022.943227

Ejemplares similares

Editorial: Hypoxia in cardiovascular disease
por: Bilo, Grzegorz, et al.
Publicado: (2022)

Editorial: Autoimmunity and cardiovascular diseases
por: Khandker, Shahad Saif, et al.
Publicado: (2023)

Editorial: Cytokines, novel cell death models and pathways in cardiovascular diseases
por: Cai, Yang-Wei, et al.
Publicado: (2023)

Editorial: Immunomodulatory Approaches in Cardiovascular Diseases
por: Booz, George W., et al.
Publicado: (2022)

Editorial: Renal function and related biomarkers in cardiovascular risk assessment and prevention
por: Lin, Gen-Min, et al.
Publicado: (2022)

Editorial: Epigenetic Regulation in Cardiovascular Diseases
por: Pillai, Indulekha C. L., et al.
Publicado: (2022)

Editorial: Cardiovascular involvement in autoimmune diseases
por: Mavrogeni, Sophie I., et al.
Publicado: (2022)

Editorial: Mitochondria, metabolism and cardiovascular diseases
por: Koga, Jun-ichiro, et al.
Publicado: (2022)

Editorial: Bio-materials for Cardiovascular Diseases
por: Campagnolo, Paola, et al.
Publicado: (2021)

Editorial: Mitochondrial Dysfunction and Cardiovascular Diseases
por: Sadoshima, Junichi, et al.
Publicado: (2021)

Editorial: Highlights for Cardiovascular Therapeutics in 2021 – Trained Immunity, Immunometabolism, Gender Differences of Cardiovascular Diseases, and Novel Targets of Cardiovascular Therapeutics
por: Yang, William Y., et al.
Publicado: (2022)

Editorial: Safety of Polyphenolic Compounds and Their Role in Cardiovascular Diseases
por: Ahmed, Lamiaa A., et al.
Publicado: (2022)

Editorial: Novel Approaches in Cardiovascular Imaging: Case Reports
por: Karanasos, Antonios, et al.
Publicado: (2022)

Editorial: Extracellular Vesicle-Mediated Processes in Cardiovascular Diseases
por: Koenen, Rory R., et al.
Publicado: (2018)

Editorial: Insights in cardiovascular therapeutics: 2021 – cell death, cardiovascular injuries, and novel targets of cardiovascular therapeutics
por: Xu, Keman, et al.
Publicado: (2022)

Editorial: Highlights in Lipids in Cardiovascular Disease: 2021
por: Boucheniata, Chaymae, et al.
Publicado: (2022)

Editorial: Mitophagy and mitochondrial proteostasis in cardiovascular diseases
por: Dymkowska, Dorota, et al.
Publicado: (2022)

Editorial: Insights in lipids in cardiovascular disease: 2021
por: Levitan, Irena, et al.
Publicado: (2022)

Editorial: Metabolic regulation in cardiovascular homeostasis and disease
por: Song, Kunhua, et al.
Publicado: (2022)

Editorial: Cardiovascular responses and diseases at high altitude
por: Huang, Lan
Publicado: (2022)

Editorial: Vascular Endothelial Glycocalyx in Cardiovascular Disease
por: Tomita, Hiroyuki, et al.
Publicado: (2022)

Editorial: Sleep disorders, hypertension and cardiovascular diseases
por: Bisogni, Valeria, et al.
Publicado: (2022)

Editorial: The Non-coding Genome and Cardiovascular Disease
por: Mishra, Paras Kumar, et al.
Publicado: (2019)

Editorial: Cardioimmunology: Inflammation and Immunity in Cardiovascular Disease
por: Lazzerini, Pietro Enea, et al.
Publicado: (2019)

Editorial: Health technology assessment in cardiovascular diseases
por: Shah, Komal, et al.
Publicado: (2023)

Editorial: Cardiovascular cell senescence in aging and disease
por: Gaetano, Carlo, et al.
Publicado: (2023)

Editorial: Micro- and macronutrient malnutrition in cardiovascular disease
por: Hobkirk, J. P., et al.
Publicado: (2023)

Editorial: Endothelial-to-mesenchymal transition in cardiovascular disease
por: Alfaidi, Mabruka, et al.
Publicado: (2023)

Editorial: Thrombo-inflammation in cardiovascular disease and health
por: Jung, Richard G., et al.
Publicado: (2023)

Editorial: Immune and autoimmune mechanisms in cardiovascular disease
por: Winkels, Holger, et al.
Publicado: (2023)

Editorial: Mitochondrial quality control in cardiovascular diseases
por: Zhang, Miao, et al.
Publicado: (2023)

Editorial: Cardiovascular engineering
por: Ozturk, Caglar, et al.
Publicado: (2022)

Editorial: Physical activity and exercise for the prevention and management of cardiovascular risk and cardiovascular disease
por: Volterrani, Maurizio, et al.
Publicado: (2023)

Editorial: Cardiovascular diseases in autoimmune diseases: Dyslipidemia and vascular inflammation
por: Solow, E. Blair, et al.
Publicado: (2022)

Editorial: Inflammation and immunomodulation in cardiovascular remodeling
por: Ewing, Mark, et al.
Publicado: (2022)

Editorial: Oxidative Stress in Cardiovascular Diseases and Pulmonary Hypertension
por: Parajuli, Nirmal, et al.
Publicado: (2022)

Editorial: Role of the Platelet Phenomenon in Cardiovascular Diseases and Cancer
por: Panova-Noeva, Marina, et al.
Publicado: (2022)

Editorial: Insulin Resistance, Metabolic Syndrome, and Cardiovascular Disease
por: Yan, Tong, et al.
Publicado: (2022)

Editorial: The importance of the central hemodynamic in the cardiovascular diseases development
por: Vilela-Martin, Jose Fernando, et al.
Publicado: (2022)

Editorial: Exosomes in cardiovascular diseases: Mechanism, diagnosis, and therapy
por: Zhang, Xiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a4go50c3mf2bql9nnaaabsnslt